ARGENX SE is 1.7x more valuable than Revolution Medicines, Inc. by market capitalization ($53.35 B vs $30.74 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | RVMD | ARGX |
|---|---|---|
| Market cap | $30.74 B | $53.35 B |
| US-listed rank | #453 | #306 |
| Revenue (latest FY) | $0.00 | - |
| Net income (latest FY) | -$1.13B | - |
| SEC filings | 782 | 272 |
ARGENX SE is 1.7x more valuable than Revolution Medicines, Inc. by market capitalization ($53.35 B vs $30.74 B).
Full pages: Revolution Medicines, Inc. and ARGENX SE, or browse the full rankings.